British Journal of Cancer - Table of Contents alert Volume 119 Issue 6

Advertisement Researchoncology.com Explore the latest science, research, and clinical trials in hematology and oncology. TABLE OF CONTENTS Volume 119, Issue 6 In this issue Editorial Article Brief Communication Article Brief Communication Article Correspondence Also new AOP Advertisement ========================================== Register for the latest nature.com webcast ========================================== Distinct Metabolic Profiling of Invading PANC-1 Pancreatic Cancer Cells During this webcast Dr. Mayumi Fujita of the National Institutes for Quantum and Radiological Science and Technology in Japan will address the method of real-time imaging of invading cells using the IncuCyte Live-Cell Analysis System, and describe how this model is useful for many studies.  Register for FREE today  Sponsored by IncuCyte Editorial Childhood cancer in the UK: achievements and legacy of six decades of research in Oxford Colin R. Muirhead British Journal of Cancer 2018 119 :659 - 660; August 21, 2018; 10.1038/s41416-018-0222-7 Abstract | Full Text Reinvigorating tumour-infiltrating lymphocytes from checkpoint inhibitor resistant melanomas Inês Pires da Silva, Marcel Batten & Georgina V. Long British Journal of Cancer 2018 119 :661 - 662; August 21, 2018; 10.1038/s41416-018-0218-3 Abstract | Full Text Article Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma Thomas Powles, Robert J. Motzer, Bernard Escudier, Sumanta Pal, Christian Kollmannsberger et al. British Journal of Cancer 2018 119 :663 - 669; September 10, 2018; 10.1038/s41416-018-0164-0 Abstract | Full Text Brief Communication Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006 Omid Hamid, Caroline Robert, Antoni Ribas, F. Stephen Hodi, Euan Walpole et al. British Journal of Cancer 2018 119 :670 - 674; September 11, 2018; 10.1038/s41416-018-0207-6 Abstract | Full Text Article A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L Tomonari Sasaki, Takashi Seto, Takeharu Yamanaka, Naonobu Kunitake, Junichi Shimizu et al. British Journal of Cancer 2018 119 :675 - 682; September 12, 2018; 10.1038/s41416-018-0243-2 Abstract | Full Text BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer Irina Tsibulak, Verena Wieser, Christine Degasper, Giridhar Shivalingaiah, Sören Wenzel et al. British Journal of Cancer 2018 119 :683 - 692; August 15, 2018; 10.1038/s41416-018-0217-4 Abstract | Full Text Brief Communication Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma David S. Ziegler, Marie Wong, Chelsea Mayoh, Amit Kumar, Maria Tsoli et al. British Journal of Cancer 2018 119 :693 - 696; September 17, 2018; 10.1038/s41416-018-0251-2 Abstract | Full Text Article A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS Simon Gollins, Nicholas West, David Sebag-Montefiore, Shabbir Susnerwala, Stephen Falk et al. British Journal of Cancer 2018 119 :697 - 706; August 17, 2018; 10.1038/s41416-018-0209-4 Abstract | Full Text Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma Joaquim Bellmunt, Aly-Khan A. Lalani, Sussana Jacobus, Stephanie A. Wankowicz, Laura Polacek et al. British Journal of Cancer 2018 119 :707 - 712; September 17, 2018; 10.1038/s41416-018-0261-0 Abstract | Full Text Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis Christoph Krisp, Robert Parker, Dana Pascovici, Nicholas K. Hayward, James S. Wilmott et al. British Journal of Cancer 2018 119 :713 - 723; August 17, 2018; 10.1038/s41416-018-0227-2 Abstract | Full Text A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma Aisha A. Hussein, Tymour Forouzanfar, Elisabeth Bloemena, JGAM de Visscher, Ruud H. Brakenhoff et al. British Journal of Cancer 2018 119 :724 - 736; August 21, 2018; 10.1038/s41416-018-0233-4 Abstract | Full Text Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with bone metastases Quirina C. B. S. Thio, W. Alexander Goudriaan, Stein J. Janssen, Nuno Rui Paulino Pereira, Daniel M. Sciubba et al. British Journal of Cancer 2018 119 :737 - 743; August 17, 2018; 10.1038/s41416-018-0231-6 Abstract | Full Text Exosomes from BM-MSCs increase the population of CSCs via transfer of miR-142-3p Hongdan Li & Feng Li British Journal of Cancer 2018 119 :744 - 755; September 17, 2018; 10.1038/s41416-018-0254-z Abstract | Full Text Childhood cancer research in Oxford I: the Oxford Survey of Childhood Cancers JF Bithell, GJ Draper, T Sorahan & CA Stiller British Journal of Cancer 2018 119 :756 - 762; August 21, 2018; 10.1038/s41416-018-0180-0 Abstract | Full Text Childhood cancer research in Oxford II: The Childhood Cancer Research Group Gerald J. Draper, John F. Bithell, Kathryn J. Bunch, Gerald M. Kendall, Michael F. G. Murphy et al. British Journal of Cancer 2018 119 :763 - 770; August 21, 2018; 10.1038/s41416-018-0181-z Abstract | Full Text Childhood cancer research in oxford III: The work of CCRG on ionising radiation Gerald M. Kendall, John F. Bithell, Kathryn J. Bunch, Gerald J. Draper, Mary E. Kroll et al. British Journal of Cancer 2018 119 :771 - 778; August 21, 2018; 10.1038/s41416-018-0182-y Abstract | Full Text Correspondence Comment on 'Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?' Yuying Liu & Xianchun Meng British Journal of Cancer 2018 119 :779 - 780; September 12, 2018; 10.1038/s41416-018-0241-4 Abstract | Full Text Reply to 'Comment on 'Circulating Neutrophils in patients with hepatocellular carcinoma" Stephen L. Chan, Richard J. Q. McNally & Helen L. Reeves British Journal of Cancer 2018 119 :781 - 782; September 12, 2018; 10.1038/s41416-018-0250-3 Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. This email has been sent to edgeblog.alerts.2011.001@gmail.com. If you no longer wish to receive the email alerts from British Journal of Cancer click here to unsubscribe . If you wish to discontinue all email services from Nature Research please click here to unsubscribe . For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Research | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.